Latest fiscal year 2025 · computed deterministically from XBRL 10-K data · coverage 100%
In fiscal 2025, RxSight, Inc. reported revenue of $134M, down 3.9% year over year. Operating margin was -35.8% and net margin -29.0%, on a free-cash-flow margin of -14.4% with capital expenditure at 2.8% of revenue. Every figure is computed directly from RXST's SEC XBRL 10-K filing — deterministic, with no estimates.
| Fiscal year | Revenue | Op margin | Net margin |
|---|---|---|---|
| FY2025 | $134M | -35.8% | -29.0% |
| FY2024 | $140M | -26.3% | -19.6% |
| FY2023 | $89M | -56.2% | -54.6% |
| FY2022 | $49M | -129.2% | -136.2% |
| FY2021 | $23M | -233.6% | -215.5% |
How does RXST compare against its actual peer set?
A CompsDesk subscription covers unlimited benchmark packs on any covered company: up to 19 metrics (6 core guaranteed) × up to 5 fiscal years × up to 12 chosen peers, percentile placement, the subject's figures cited to their SEC tag, form and period with every company identified by its CIK, PDF-ready HTML + CSV, generated on demand.
Related in the same sector: A · ACHR · AEHR · AERG · AEVA · AIRI
Source: SEC EDGAR XBRL (10-K filings), latest filed values. "n/a" = not disclosed under mapped tags — never estimated. Informational benchmarking, not investment advice. © CompsDesk / Sam Arora.